Stable solid dosage forms of aminopterin
There is disclosed stable pharmaceutical compositions containing pharmaceutically acceptable salts of aminopterin surface deposited onto solid excipients. The stable pharmaceutical compositions are hermetically sealed from the atmosphere. The formation of degradation products of aminopterin is reduced or eliminated.
1. A stable pharmaceutical composition of aminopterin disodium salt, wherein the composition comprises
a plurality of granules having a solid body and a surface, wherein the solid body consists of microcrystalline cellulose and lactose monohydrate, and wherein the surface of the solid body consists of aminopterin disodium salt, and
an excipient comprising lactose, silicon dioxide, sodium croscarmellose,
magnesium stearate, and no aminopterin disodium salt,
wherein the granules are coated by the excipient, and wherein the aminopterin disodium salt comprises 0.01 to 10 weight percent of the composition.
2. The stable pharmaceutical composition of claim 1 , wherein the aminopterin salt is from about 0.1 weight percent to about 1 weight percent of the composition.
3. The stable pharmaceutical composition of claim 1 , wherein the aminopterin disodium salt is from about 0.25 weight percent to about 1 weight percent of the composition.
4. The stable pharmaceutical composition of claim 1 , wherein the composition is in a form of a capsule, caplet, powder, disc, or tablet.
5. A method for preparing a stable pharmaceutical composition of an aminopterin salt, comprising:
(a) mixing a solution consisting of an aminopterin salt and a solvent;
(b) adding the solution of step (a) to a solid body consisting of microcrystalline cellulose and lactose monohydrate to form a wet granulation; and
(c) drying the wet granulation to form granules.
6. The method for preparing a stable pharmaceutical composition of claim 5 , further comprising mixing one or more additional excipients with the dried granules to form a pharmaceutical composition.
7. The method for preparing a stable pharmaceutical composition of claim 5 , wherein the solvent is water.
8. The method for preparing a stable pharmaceutical composition of claim 5 , wherein step (c) is performed in a fluid bed dryer.
9. The method for preparing a stable pharmaceutical composition of claim 6 , further comprising the step of compressing the pharmaceutical composition into a tablet.
10. The stable pharmaceutical composition of claim 4 , wherein the total amount of aminopterin disodium salt in the capsule, caplet, disc, or tablet is from 0.01 mg to 4 mg.
11. The stable pharmaceutical composition of claim 1 , wherein the composition is in a form of a tablet.
12. The stable pharmaceutical composition of claim 1 , wherein the composition is prepared by
(a) mixing the aminopterin salt and a solvent, to form a solution;
(b) adding the solution of step (a) to the solid bodies to form a wet granulation; and
(c) drying the wet granulation to form dried granules.
13. The stable pharmaceutical composition of claim 12 , wherein the dried granules are mixed with one or more additional excipients.